Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct 12;23(11):19.
doi: 10.1007/s11894-021-00818-1.

What is the Evidence for Over the Counter Laxatives to Treat Childhood Constipation?

Adam Paul  1 , Jaya Punati  2
Affiliations
Review

What is the Evidence for Over the Counter Laxatives to Treat Childhood Constipation?

Adam Paul et al. Curr Gastroenterol Rep. .

Abstract

Purpose of review: Functional constipation is a common pediatric GI disorder that is responsible for a significant portion of pediatric office visits each year. It presents a significant stressor for patients, their families, and providers alike. There are a variety of over the counter agents available for treatment of pediatric constipation.

Recent findings: Osmotic laxatives, such as polyethylene glycol 3350 (PEG 3350) and lactulose, remain the most effective and safe therapy for both long and short term treatment of pediatric functional constipation. Stimulant laxatives, like Senna and Bisacodyl, probiotics, fiber preparations, enemas, and suppositories make excellent choices for adjunct therapies in specific clinical scenarios. There are multiple over the counter pharmacologic agents with various mechanisms of action that have demonstrated efficacy in pediatric functional constipation. These therapies are generally safe and well tolerated by patients.

Keywords: Constipation; Functional constipation; Laxative; Pediatrics.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance
    1. Liem O, Harman J, Benninga M, Kelleher K, Mousa H, Di Lorenzo C. Healthutilization and cost impact of childhood constipation in the United States. J Pediatr. 2009;154(2):258–62. https://doi.org/10.1016/j.jpeds.2008.07.060 . - DOI - PubMed
    1. van den Berg MM, Benninga MA, Di Lorenzo C. Epidemiology of childhoodconstipation: a systematic review. Am J Gastroenterol. 2006;101(10):2401–9. https://doi.org/10.1111/j.1572-0241.2006.00771.x . - DOI - PubMed
    1. Tabbers MM, Di Lorenzo C, Berger MY, et al. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr. 2014;58(2):258–74. https://doi.org/10.1097/MPG.0000000000000266 . - DOI - PubMed
    1. Koppen IJ, Nurko S, Saps M, Di Lorenzo C, Benninga MA. The pediatric Rome IV criteria: what’s new? Expert Rev Gastroenterol Hepatol. 2017;11(3):193–201. https://doi.org/10.1080/17474124.2017.1282820 . - DOI - PubMed
    1. Modin L, Walsted AM, Dalby K, Jakobsen MS. Polyethylene glycolmaintenance treatment for childhood functional constipation: a randomized, placebo-controlled trial. J Pediatr Gastroenterol Nutr. 2018;67(6):732–7. https://doi.org/10.1097/MPG.0000000000002070 . - DOI - PubMed

MeSH terms

LinkOut - more resources